126 related articles for article (PubMed ID: 9322148)
1. Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression.
Mozzanica N; Cattaneo A; Fracchiolla N; Boneschi V; Berti E; Gronda E; Mangiavacchi M; Finzi AF; Neri A
J Heart Lung Transplant; 1997 Sep; 16(9):964-8. PubMed ID: 9322148
[TBL] [Abstract][Full Text] [Related]
2. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
Rustgi VK
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
[No Abstract] [Full Text] [Related]
4. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
Transplantation; 1995 Feb; 59(4):637-40. PubMed ID: 7533350
[No Abstract] [Full Text] [Related]
5. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
7. [Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation].
Tas S; Simonart T; Dargent J; Kentos A; Antoine M; Knoop C; Estenne M; De Dobbeleer G
Ann Dermatol Venereol; 2000 May; 127(5):488-91. PubMed ID: 10863178
[TBL] [Abstract][Full Text] [Related]
8. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
Perera SM; Thomas JA; Burke M; Crawford DH
J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient.
Chiu LS; Choi PC; Luk NM; Chang M; Tang WY
Clin Exp Dermatol; 2009 Jul; 34(5):e21-4. PubMed ID: 19508468
[TBL] [Abstract][Full Text] [Related]
11. [Lymphoma with bladder involvement and renal transplantation].
Chebil M; Martin X; Friaa S; Ezzeddine W; Garnier JL; Desmettre O; Maréchal JM; Gelet A; Dubernard JM
Prog Urol; 1995 Feb; 5(1):102-5. PubMed ID: 7719353
[TBL] [Abstract][Full Text] [Related]
12. Overview of posttransplant B-cell lymphoproliferative disorders.
Swinnen LJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
[TBL] [Abstract][Full Text] [Related]
13. Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma.
Kikuchi A; Anzai H; Kosuge H; Naka W; Nishikawa T
Br J Dermatol; 1997 Jan; 136(1):124-8. PubMed ID: 9039311
[TBL] [Abstract][Full Text] [Related]
14. [Post-transplantation lymphomas and Epstein-Barr virus].
Caillard S; Heibel F; Benaicha M; Moulin B
Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
[TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin].
Mihara H; Kato Y; Tokura Y; Hattori Y; Sato A; Kobayashi H; Imamura A; Daimaru O; Miwa H; Nitta M
Rinsho Ketsueki; 1999 Dec; 40(12):1258-64. PubMed ID: 10658479
[TBL] [Abstract][Full Text] [Related]
16. Treatment of lympho-proliferative disease with rituximab.
Niedermeyer J; Hoffmeyer F; Hertenstein B; Hoeper MM; Fabel H
Lancet; 2000 Feb; 355(9202):499. PubMed ID: 10841158
[No Abstract] [Full Text] [Related]
17. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
19. T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience.
Draoua HY; Tsao L; Mancini DM; Addonizio LJ; Bhagat G; Alobeid B
Br J Haematol; 2004 Nov; 127(4):429-32. PubMed ID: 15521920
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
